Case Study

Fixed Dose Combination Drugs

Source: Cambrex

A large, multinational pharmaceutical company was seeking a CDMO partner with the expertise and technological capabilities to combine three drug substances into a fixed dose combination (FDC) product suitable for adult and pediatric dosing.

The incompatibility of one of the APIs with the other two and the need for flexible dosing for a diverse patient population were key challenges. These were overcome using a combination of multi-layer tablets for adults, mini-tablets for pediatric patients, and polymer coating technologies. In a second case, microparticulate technology was used to meet a customer’s needs for combining two APIs with different release profiles.

Read more about meeting the challenges for FDCs.


Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Drug Discovery Online? Subscribe today.

Subscribe to Drug Discovery Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Drug Discovery Online